RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 12-22
  • Bills Seeks To Restrict Smoking In Cars, E-Cigarettes In Public Places

    Bills Seeks To Restrict Smoking In Cars, E-Cigarettes In Public Places
    State legislators gave initial approval Monday to one bill that would ban smoking in cars with small children, and another that would institute tough new rules on electronic cigarettes. Both measures cleared the Public Health Committee, and now move to...
  • GNC announces new supplement guidelines, reaches deal with NY Attorney General

    GNC announces new supplement guidelines, reaches deal with NY Attorney General
    GNC Holdings Inc. said Monday that it has reached a deal with New York Attorney General Eric Schneiderman over its Herbal Plus products. In February, Schneiderman's office sent letters to GNC, Target, Walmart and Walgreens for allegedly selling store...
  • Md. ignores teen cancer risk

    Md. ignores teen cancer risk
    By rejecting state Sen. Jamie Raskin's bill to make tanning-salon ultraviolet ray machines off-limits to minors, the Senate's Finance Committee has put itself at odds with every major national and state medical group to look at the issue, including the...
  • Olympus says new steps needed to clean medical scopes of dangerous bugs

    Olympus Corp., the maker of medical scopes linked to recent deadly superbug outbreaks, reversed course Thursday and said it was issuing an urgent update on how the device should be cleaned. Under fire from lawmakers, hospitals and doctors, the Japanese...
  • Powdered alcohol faces stiff opposition

    Powdered alcohol faces stiff opposition
    Imagine: You've spent all morning and most of the afternoon on a hiking and kayaking trip, your muscles aching that good kind of ache and your folding chair calling to you as you return to camp in the orange-shifted light of the early evening. If...
  • Should You Use An Off-Label Drug?

    An off-label drug should be used when an on-label drug, approved for a specific condition, either does not work or is not approved by an insurer. Ask your doctor: >> Is this drug approved for my condition? >> If it's off-label, has it been shown...
  • Excerpts from recent Wisconsin editorials

    Milwaukee Journal Sentinel, March 23 Voter ID is the law; live with it Let's be clear about something: Voter ID is a mistake. Plain and simple. But let's be clear about something else: It is now the law in Wisconsin, after the U.S. Supreme Court on...
  • FDA to scrutinize unproven alternative remedies

    FDA to scrutinize unproven alternative remedies
    Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine. The Food and Drug Administration announced Thursday...
  • Steve Smith, leading U.S. tea connoisseur and entrepreneur, dies at 65

    Steven Smith, a Portland, Ore., entrepreneur whose enchantment with tea and wizardry at blending flavors helped turn the United States into a nation of tea connoisseurs, died Monday at his home in Lake Oswego, Ore. He was 65. The cause was complications...
  • Water: What you need to know about keeping hydrated

    Water: What you need to know about keeping hydrated
    For two decades, we've been encouraged — some might say hounded — into making drinking water a habit. We carry it in plastic bottles, reusable canisters, on our backs to suck through elaborate tubing. We might even hire a doctor to have it...
  • Hospira's first biosimilar could be its first to gain FDA approval

    Lake Forest-based Hospira released clinical data Friday for its drug Retacrit, which could become the company's first U.S.-approved biosimilar drug. Retacrit, approved in Europe since 2008, treats anemia as a similar, low-cost version of Amgen's biologic...